Navigation Links
Haemonetics Reports Third Quarter of Fiscal 11
Date:1/31/2011

s186,054170,1739.3%Operating income 81,65479,1843.1%Interest income/(expense), net400(413)(196.9%)Other expense, net(544)(1,389)(60.9%)Income before taxes81,51077,3825.3%Tax expense22,51822,973(2.0%)NET INCOME$58,992$54,4098.4%Net income per common shareassuming dilution $2.32$2.0811.2%Weighted average number of sharesBasic24,93325,544Diluted25,47726,150Profit Margins:Inc/(Dec) vs
prior year profit
margin % Gross profit52.8%52.4%0.4%R&D4.7%4.1%0.6%S,G&A32.4%31.6%0.8%Operating income16.1%16.6%(0.5%)Income before taxes16.1%16.2%(0.1%)Net income11.6%11.4%0.2%Revenue Analysis for the Third Quarter and Year-To-Date FY11 and FY10Third Quarter1/1/2011
As Reported12/26/2009
As Reported% Inc/(Dec) vs
Prior YearRevenues by geographyUnited States

$79,844$74,9976.5%International

$96,945$90,1727.5%Net revenues

$176,789$165,1697.0%Disposable revenuesPlasma disposables

$59,814$59,1771.1%Blood bank disposablesPlatelet

$41,057$39,7933.2%Red cell

$11,676$12,022(2.9%)$52,732$51,8151.8%Hospital disposablesSurgical

$17,117$17,864(4.2%)OrthoPAT

$9,248$9,864(6.2%)Diagnostics

$5,220$4,33120.5%$31,584$32,059(1.5%)Subtotal

$144,130$143,0510.8%Software solutions

$16,571$8,256100.7%Equipment & other

$16,088$13,86216.1%Net revenues

$176,789$165,1697.0%Nine Months Ended1/1/2011
As Reported12/26/2009
As Reported% Inc/(Dec) vs
Prior YearRevenues by geographyUnited States

$237,893$225,2235.6%International

$268,768$251,1037.0%Net revenues

$506,661$476,3266.4%Disposable revenuesPlasma disposables

$172,245$177,469(2.9%)Blood bank disposablesPlatelet

$117,120$111,3505.2%Red cell

$34,284$
'/>"/>

SOURCE Haemonetics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Haemonetics Receives Favorable Ruling in Patent Lawsuit against Competitive Technology
2. Neogen Reports 33% Increase in Net Income
3. Cardium Reports Excellagen Matrix Clinical Study Results Accepted for Publication by Peer-Reviewed Journal, and Updates Product Plans
4. New Topical Patent Research Reports Recently Published at MarketPublishers.com
5. YM BioSciences Reports Positive Interim Data Including Substantial Anemia Response from Phase I/II Trial of JAK1/JaK2 Inhibitor CYT387
6. Oncothyreon Reports Positive Data from Phase 1 Clinical Trial of PI3-Kinase Inhibitor PX-866 in Patients with Relapsed or Refractory Solid Tumors
7. GeneLink Reports Third Quarter Results
8. Imagenetix, Inc. Reports Second Quarter 2011 Results
9. Transgenomic Reports Third Quarter Financial Results
10. Tiens Biotech Group (USA) Reports Third Quarter and Nine-Month Results
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2011 Results; Teleconference and Webcast to be held on November 16, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 InferMed , ... will ... evidence-based clinical s olutions suite   ... information products and services, announced today the acquisition of  InferMed ... (CDS) technology company. InferMed,s Arezzo technology supports clinicians ...
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix ... of common shares of Resverlogix have approved the ... Eastern Capital Limited of 5,600,000 units at a ... Placement"), each unit being comprised of one common ... aggregate proceeds of approximately CAD$15 million; and (ii) ...
(Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... July 1 Liko, a major supplier of,patient ... industry,has announced two new additions to its "Stat" ... Both new products, the Stat HandySheet(TM) and the ... patients or the movement of,patients in bed., ...
... (67%) of Americans are generally concerned about ... according to a 2008 National Consumer Water ... warning of contaminants1 (i.e. lead, radium, chlorine) ... controversy and confusion. Consumers are also learning ...
... July 1 Neogen Corporation,(Nasdaq: NEOG ) ... line used in,animal health and hygiene applications from ... 14 different product formulations,along with manufacturing process know-how ... were not disclosed., The addition of these ...
Cached Biology Technology:Liko Introduces Two Additions to Its 'Stat' Family of Low Friction Sheets 2 Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home 2 Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home 3Neogen Acquires Product Line From DuPont Animal Health Solutions 2
(Date:6/24/2015)... -- The biologics safety testing market is growing at ... include growth of the pharmaceutical and biological industries and ... years, the number of drug approvals in North American ... approved 225 drug applications and Health Canada approved 99. ... accounted for 3,822 of the pharmaceutical and 1,998 ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... USC have unlocked the mystery of why new cases of ... that causes the disease disproportionately increases a normal father,s production ... Noonan syndrome mutation arises in a normal sperm stem cell ... stem cells lacking the mutation. The father then is more ...
... , June 6, 2013 Research and ... the "DNA Microarray 2013: A Focus on Sales ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,DNA Microarray 2013 presents the ... involving the participation of 201 buyers and end-users in ...
... a new field in medicine curing diseases by replacing ... artificial limb replaces the function of a leg or arm ... science on the cusp of chemistry and biology who focuses ... water. They will deliver the next talks in the ...
Cached Biology News:DNA Microarray 2013 Market Report: A Focus on Sales Growth 2Medicine, energy topics of Kavli lectures at American Chemical Society meeting 2Medicine, energy topics of Kavli lectures at American Chemical Society meeting 3
...
Pronase Reagent...
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Biology Products: